Financials
- Market Capitalization 649.06 M
- Employee 61
- Founded 2006
- CEO N/A
- Website www.zevra.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG1F5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
6.64
Fiyat/satışlar oranı
4.82
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2654 | AURA Aura Biosciences, Inc. - Common Stock | 6.40 USD | -2.14% | +3.23% | -9.22% | +4.92% | 663.71 M USD | ||
| 2659 | PHAR Pharming Group N.V. - ADS, each representing 10 | 9.55 USD | -0.62% | -1.65% | -11.41% | -34.81% | 670.10 M USD | ||
| 2672 | IMMX Immix Biopharma, Inc. - Common Stock | 8.90 USD | -3.78% | -10.28% | -28.46% | +260.32% | 636.70 M USD | ||
| 2681 | PRME Prime Medicine, Inc. - Common Stock | 3.51 USD | -2.77% | -4.62% | +12.50% | -35.95% | 636.63 M USD |